Yarrow Bioscience, Inc.
YARW
Last
$19.71
Day
-0.8%
1y
—
5y
—
52w
—
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0526d
EMA 21
—
EMA 50
—
EMA 200
—
20d high
—
5y high
—
5y range
—
Positions held
Your positionsYARW isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
—
Hold
—
Signal
—
Target
—
Stop
—
Stop distance
—
Target vs last
—
Fundamentals
| Market cap | $184.88M | Enterprise value | $141.74M | Trailing P/E | — | Forward P/E | -12.04 |
| PEG | — | Price / book | — | Beta | 2.08 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | 1.40 | Free cash flow | — | Analyst recommendation | none | Mean target | $57.00 |
| 52w high | $46.95 | 52w low | $16.05 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q2 | |
|---|---|---|---|---|
| Revenue | $0.1M | $0.0M | $0.0M | $0.1M |
| Op margin | -3197.9% | — | — | -10930.4% |
| Net income | -$3.0M | -$2.7M | -$71.0M | -$5.8M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$3.1M | -$2.9M | -$1.0M | -$7.5M |
- Operating margin expanded to -3197.9%.
Yearly (6y)
No data yet.
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-14 · Yarrow Bioscience Closes $172.5 Million Public Offering
2026-09-11 · Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
2026-09-10 · Yarrow Bioscience Launches Public Offering of Common Stock
2026-09-10 · Yarrow Bioscience Announces Proposed Underwritten Public Offering
2026-08-13 · Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update
Price (daily)
Full chart · RSI · MACD · patternsNo price history yet for YARW.
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin